Listar DMed-Artículos, capítulos... por autor "f7a0cc5d-1731-4040-850d-f11a6b36a7b4"

Mostrando ítems 1-3 de 3

    • Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer 

      Pérez Sánchez, Carlos; Barbarroja, Nuria; Pantaleão, Lucas C.; López-Sánchez, Laura M.; Ozanne, Susan E.; Jurado-Gámez, Bernabé; Jurado-Gámez, Bernabé; Aranda Aguilar, Enrique; López-Pedrera, Ch.; Rodríguez-Ariza, Antonio (MDPI, 2021)
      This study represents a novel proof of concept of the clinical utility of miRNAs from exhaled breath condensate (EBC) as biomarkers of lung cancer (LC). Genome-wide miRNA profiling and machine learning analysis were performed ...

    • Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis 

      López-Pedrera, Ch.; Barbarroja, Nuria; Patiño-Trives, Alejandra Mª; Luque-Tévar, María; Collantes Estévez, Eduardo; Escudero Contreras, Alejandro; Pérez Sánchez, Carlos (MDPI, 2020)
      Rheumatoid arthritis (RA) is an autoimmune and chronic inflammatory disease primarily affecting the joints, and closely related to specific autoantibodies that mostly target modified self-epitopes. Relevant findings in the ...

    • The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast 

      Arias de la Rosa, Iván; López-Montilla, María Dolores; Román-Rodríguez, Cristobal; Pérez Sánchez, Carlos; Gómez-García, Ignacio; López Medina, Eloísa Clementina; Ladehesa-Pineda, Lourdes; Ábalos-Aguilera, María del Carmen; Ruiz, Desireé; Patiño-Trives, Alejandra Mª; Luque-Tévar, María; Añón-Oñate, Isabel; Pérez-Galán, María José; Guzmán Ruiz, R.; Malagón, María M.; López-Pedrera, Ch.; Escudero Contreras, Alejandro; Collantes Estévez, Eduardo; Barbarroja, Nuria (Wiley, 2022)
      Objectives: (1) To evaluate clinical and molecular cardiovascular disease (CVD) signs and their relationship with psoriatic arthritis (PsA) features and (2) to identify a clinical patient profile susceptible to benefit ...